Trial Profile
Pharmacokinetics, Safety and Tolerability of Cyclosporine or Tacrolimus Following Coadministration of ABT-450/r, ABT-267 and ABT-333 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Paritaprevir (Primary) ; Ciclosporin; Tacrolimus
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors AbbVie
- 22 Dec 2015 New trial record